NBH Bank
ATOS icon

NBH Bank’s Atossa Therapeutics ATOS Stock Holding History

NBH Bank’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$135 Buy
+69
New +$164 ﹤0.01% 610

Other funds holding ATOS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Rydar Equities
Rydar Equities Weatherford, Texas $194M AUM 23.21% 1-Year Est. Return
Harbour Investments
Harbour Investments Madison, Wisconsin $6.75B AUM 16.25% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

NBH Bank's ATOS Position: Q3 2026 in Review

NBH Bank opened a new position in Atossa Therapeutics (ATOS) in Q3 2026: 69 shares worth $135. The stake represents ﹤0.01% of the portfolio and ranks #610 among its holdings.

14 funds tracked by Wall St. Rank hold ATOS as of Q3 2026.

  • NBH Bank held 69 shares of Atossa Therapeutics worth $135 as of Q3 2026.
  • Atossa Therapeutics was a new NBH Bank position in Q3 2026.
  • Atossa Therapeutics made up ﹤0.01% of NBH Bank's portfolio in Q3 2026, its #610 holding.
  • 14 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2026.

Based on NBH Bank's 13F filing for Q3 2026, filed 5 Nov 2026.